Over-activation of endocannabinoids and increased expression of cannabinoid receptor 1 (CB1R) in adipose tissue had been confirmed under condition of morbid obesity (1, 2), and CB1R had been proved to be an attractive target in developing novel anti-obesity drugs (3–6). Here, CNR1 is linked to obesity disorder.